Cover Image

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial

The COSMIC trial is designed to evaluate toxicity in dose-escalated treatment with intensity-modulated radiotherapy (IMRT) and carbon ion boost for malignant salivary gland tumors (MSGT) of the head and neck including patients with inoperable/ incompletely resected MSGTs (R2-group) and completely re...

Full description

Saved in:
Bibliographic Details
Main Authors: Jensen, Alexandra (Author) , Nikoghosyan, Anna (Author) , Lossner, Karen (Author) , Herfarth, Klaus (Author) , Debus, Jürgen (Author) , Münter, Marc (Author)
Format: Article (Journal)
Language:English
Published: May 2, 2012
In: BMC cancer
Year: 2012, Volume: 12
ISSN:1471-2407
DOI:10.1186/1471-2407-12-163
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1471-2407-12-163
Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1471-2407-12-163
Get full text
Author Notes:Alexandra D. Jensen, Anna V. Nikoghosyan, Karen Lossner, Klaus K. Herfarth, Jürgen Debus and Marc W. Münter
Description
Summary:The COSMIC trial is designed to evaluate toxicity in dose-escalated treatment with intensity-modulated radiotherapy (IMRT) and carbon ion boost for malignant salivary gland tumors (MSGT) of the head and neck including patients with inoperable/ incompletely resected MSGTs (R2-group) and completely resected tumors plus involved margins or perineural spread (R1-group).
Item Description:Gesehen am 22.08.2018
Physical Description:Online Resource
ISSN:1471-2407
DOI:10.1186/1471-2407-12-163

Similar Items